Jump to ContentJump to Main Navigation

Online

149,00 € / $224.00*

* Prices subject to change. Shipping costs will be added if applicable.
Publication Date:
July 2011
ISSN:
2191-0251
DOI:
10.1515/jpem.2011.050

See all formats and pricing

Online
Individual Subscription Online only
Euro [D] 149.00
RRP for USA, Canada, Mexico
US$ 224.00 *
Print
Individual Subscription Online only
Euro [D] 873.00
RRP for USA, Canada, Mexico
US$ 1310.00 *
Print + Online
Individual Subscription Online only
Euro [D] 1048.00
RRP for USA, Canada, Mexico
US$ 1572.00 *
*Prices subject to change. Shipping costs will be added if applicable.

Editor-in-Chief: Zadik, Zvi

Editorial Board Member: Cassorla, Fernando / Cutfield, Wayne / de Muinck Keizer-Schrama, Sabine M.P.F. / Fideleff, Hugo L. / LaFranch, Stephen H. / Lanes M. D., Roberto / Levitsky, Lynne / Lippe, Barbara / Pfäffle, Roland / Root, Allen W. / Rosenfeld, Ron G. / Werther, George / Kiess, Wieland

12 Issues per year

IMPACT FACTOR 2011: 0.875
5-year IMPACT FACTOR: 1.026

VolumeIssuePage

Issues

Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study

Stanislava Koloušková1 / Daniela Zemková1 / Jana Bartošová1 / Veronika Skalická1 / Zdeněk Šumník1 / Věra Vávrová1 / 1

1Department of Pediatrics, Second Faculty of Medicine, Charles University in Prague and University Hospital Prague-Motol, V Uvalu 84, CZ-150 06 Praha 5, Czech Republic

Corresponding author: Prof. Jan Lebl, MD, PhD, Department of Pediatrics, Second Faculty of Medicine, Charles University in Prague, V Uvalu 84, CZ-150 06 Praha 5, Czech Republic Phone: +420 224 432 001, Fax: +420 224 432 020

Citation Information: Journal of Pediatric Endocrinology and Metabolism. Volume 24, Issue 7-8, Pages 449–454, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: 10.1515/jpem.2011.050, July 2011

Publication History:
Published Online:
2011-07-08

Abstract

Cystic fibrosis related diabetes (CFRD) is an insulinopenic condition. We aimed to detect insulinopenia early and to evaluate the impact of low dose insulin on nutritional status and forced expiratory volume in first second (FEV1). Out of 142 cystic fibrosis patients (CFpts) older than 10 years, 28 with abnormal oral glucose tolerance test in spite of normal fasting glycemia were found to have decreased first phase insulin release and started low dose insulin therapy (median age 15.4 years). Sex and age matched CFpts with normal glucose tolerance (NGT) were observed for comparison. Whereas nutritional status improved following 3 years of insulin administration, FEV1 stabilized in insulin-treated insulinopenic subjects (73.8±4.3% vs. 73.5±4.4%), but decreased in the parallel group with NGT who remained without insulin treatment (71.1±3.8% vs. 61.0±4.0%; p=0.001). We conclude that low dose insulin improves nutritional status and stabilizes pulmonary functions. Regular estimation of stimulated insulin secretion in CFpts may allow optimizing treatment.

Keywords: cystic fibrosis; cystic fibrosis related diabetes; insulinopenia; insulin treatment; pulmonary function tests

Comments (0)

Please log in or register to comment.